Ontology type: schema:Chapter
1998
AUTHORSJ. P. Marie , Z. Marjanovic , A. Vekhoff , A. Bouvet , F. Chast , M. Baudard , O. Legrand , V. Levy , B. Rio , A. Delmer , R. Zittoun
ABSTRACTTwo successive studies comparing tazocilline (12 g piperacillin + 1.5 g tazobactam/ day) + aminoside (15 mg/k/day amikacin in the first trial, 3 mg/kg/d tobramycin in the second) to ceftazidime (3 g/day) + aminoside included 466 febrile episodes in profoundly neutropenic patients after chemotherapy (or chemo-radiotherapy) for hematological malignancies. Patients were treated for acute leukemia (72%), or autografted for non-Hodgkin lymphoma or myeloma (25%), few patients for solid tumors. The mean duration of neutropenia was 21 days ± 11 (92% > 7 days); 466 febrile episodes were analysed for intention-to-treat, and were attributed to bacteremia in 119 cases, to local infection in 178 cases, and were of unknown origin (FUO) in 169 cases. A majority of Gram positive strains (55.5%) was isolated at day 0. The 72 h apyrexia was obtained more often (51.6% of the cases) with Tazocillin + aminoside than with ceftazidime + aminoside (33.6%, p < 0.0001). This results was due to a better control of bacteremia (p = 0.03) and local infection (p = 0.006) with tazocillin + aminoside, but not FUO (p = 0.19). Identical results of both antibiotic associations were observed during the first course of antitumoral chemotherapy, but tazocillin was significantly superior for 72 h apyrexia when fever occurred during consolidation therapy (p < 0.0001) or relapse treatment (p = 0.006). Superinfections due to Gram positive strains and major infectious events (infectious deaths and retardations of underlying disease treatment due to infection) were less frequent when patients received tazocillin + aminoside (respectively p = 0.002 and p = 0.02). The initial empirical antibiotic association remained unchanged and lead to a persisting apyrexia in only 20.3% of the cases treated with tazocillin + aminoside, but this was significantly better than with the other association (9.5%, p = 0.02). More... »
PAGES1058-1063
Acute Leukemias VII
ISBN
978-3-642-71962-2
978-3-642-71960-8
http://scigraph.springernature.com/pub.10.1007/978-3-642-71960-8_148
DOIhttp://dx.doi.org/10.1007/978-3-642-71960-8_148
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1014007929
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Biologique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Biologique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Marie",
"givenName": "J. P.",
"id": "sg:person.01064502270.46",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064502270.46"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Marjanovic",
"givenName": "Z.",
"id": "sg:person.01143206732.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143206732.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Vekhoff",
"givenName": "A.",
"id": "sg:person.01362131264.28",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362131264.28"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service de Microbiologie, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service de Microbiologie, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Bouvet",
"givenName": "A.",
"id": "sg:person.01154761477.72",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154761477.72"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service de Pharmacie, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service de Pharmacie, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Chast",
"givenName": "F.",
"id": "sg:person.065721244.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.065721244.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Baudard",
"givenName": "M.",
"id": "sg:person.01257751520.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257751520.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Legrand",
"givenName": "O.",
"id": "sg:person.0752753564.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Levy",
"givenName": "V.",
"id": "sg:person.01105023444.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105023444.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Rio",
"givenName": "B.",
"id": "sg:person.01245127334.86",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245127334.86"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Delmer",
"givenName": "A.",
"id": "sg:person.01014452334.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014452334.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France",
"id": "http://www.grid.ac/institutes/grid.411394.a",
"name": [
"Service d\u2019H\u00e9matologie Clinique, H\u00f4tel-Dieu de Paris, 75181, Paris Cedex 04, France"
],
"type": "Organization"
},
"familyName": "Zittoun",
"givenName": "R.",
"id": "sg:person.0717353373.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717353373.00"
],
"type": "Person"
}
],
"datePublished": "1998",
"datePublishedReg": "1998-01-01",
"description": "Two successive studies comparing tazocilline (12 g piperacillin + 1.5 g tazobactam/ day) + aminoside (15 mg/k/day amikacin in the first trial, 3 mg/kg/d tobramycin in the second) to ceftazidime (3 g/day) + aminoside included 466 febrile episodes in profoundly neutropenic patients after chemotherapy (or chemo-radiotherapy) for hematological malignancies. Patients were treated for acute leukemia (72%), or autografted for non-Hodgkin lymphoma or myeloma (25%), few patients for solid tumors. The mean duration of neutropenia was 21 days \u00b1 11 (92% > 7 days); 466 febrile episodes were analysed for intention-to-treat, and were attributed to bacteremia in 119 cases, to local infection in 178 cases, and were of unknown origin (FUO) in 169 cases. A majority of Gram positive strains (55.5%) was isolated at day 0. The 72 h apyrexia was obtained more often (51.6% of the cases) with Tazocillin + aminoside than with ceftazidime + aminoside (33.6%, p < 0.0001). This results was due to a better control of bacteremia (p = 0.03) and local infection (p = 0.006) with tazocillin + aminoside, but not FUO (p = 0.19). Identical results of both antibiotic associations were observed during the first course of antitumoral chemotherapy, but tazocillin was significantly superior for 72 h apyrexia when fever occurred during consolidation therapy (p < 0.0001) or relapse treatment (p = 0.006). Superinfections due to Gram positive strains and major infectious events (infectious deaths and retardations of underlying disease treatment due to infection) were less frequent when patients received tazocillin + aminoside (respectively p = 0.002 and p = 0.02). The initial empirical antibiotic association remained unchanged and lead to a persisting apyrexia in only 20.3% of the cases treated with tazocillin + aminoside, but this was significantly better than with the other association (9.5%, p = 0.02).",
"editor": [
{
"familyName": "Hiddemann",
"givenName": "W.",
"type": "Person"
},
{
"familyName": "B\u00fcchner",
"givenName": "T.",
"type": "Person"
},
{
"familyName": "W\u00f6rmann",
"givenName": "B.",
"type": "Person"
},
{
"familyName": "Ritter",
"givenName": "J.",
"type": "Person"
},
{
"familyName": "Creutzig",
"givenName": "U.",
"type": "Person"
},
{
"familyName": "Keating",
"givenName": "M.",
"type": "Person"
},
{
"familyName": "Plunkett",
"givenName": "W.",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-642-71960-8_148",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-642-71962-2",
"978-3-642-71960-8"
],
"name": "Acute Leukemias VII",
"type": "Book"
},
"keywords": [
"febrile episodes",
"neutropenic patients",
"antibiotic association",
"local infection",
"major infectious events",
"management of fever",
"non-Hodgkin lymphoma",
"positive strains",
"antitumoral chemotherapy",
"consolidation therapy",
"infectious events",
"mean duration",
"acute leukemia",
"hematological malignancies",
"patients",
"aminosides",
"solid tumors",
"day 0",
"apyrexia",
"unknown origin",
"Gram-positive strains",
"ceftazidime",
"bacteremia",
"chemotherapy",
"fever",
"first course",
"infection",
"episodes",
"association",
"successive studies",
"neutropenia",
"FUO",
"myeloma",
"malignancy",
"lymphoma",
"therapy",
"leukemia",
"tumors",
"superinfection",
"cases",
"better control",
"treatment",
"duration",
"treat",
"days",
"strains",
"majority",
"identical results",
"course",
"management",
"control",
"study",
"events",
"results",
"intention",
"comparison",
"origin"
],
"name": "Management of Fever in Adult Hematological Neutropenic Patients: Comparison of Tazocillin + Aminoside versus Ceftazidime + Aminoside in 466 Febrile Episodes",
"pagination": "1058-1063",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1014007929"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-642-71960-8_148"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-642-71960-8_148",
"https://app.dimensions.ai/details/publication/pub.1014007929"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-06-01T22:27",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/chapter/chapter_111.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-642-71960-8_148"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-71960-8_148'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-71960-8_148'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-71960-8_148'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-71960-8_148'
This table displays all metadata directly associated to this object as RDF triples.
223 TRIPLES
23 PREDICATES
83 URIs
76 LITERALS
7 BLANK NODES